FIELD: chemistry.
SUBSTANCE: claimed invention relates to field of biophysics. Claimed are methods of determining space-time distribution of proteolytic enzyme activity in heterogeneous system, in accordance to which: provided is system in vitro, which contains sample of blood plasma, whole blood, water, lymph, colloidal solution, crystalloid solution or gel, and proteolytic enzyme or its precursor; fluorogenic, chromogenic or luminescent substrate for said enzyme id added; space distribution of signal of released substrate label is registered at specified time moments and space-time distribution of proteolytic enzyme activity is obtained by solving reverse problem of type "reaction-diffusion-convection" taking into account label binding with medium components. Also described is device for realisation of methods in accordance with claimed invention and method of diagnosing hemostasis disorders, based on their application.
EFFECT: invention can be further applied in the study of blood coagulation system and diagnostics of diseases associated with blood coagulation disorders.
22 cl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING BLOOD PLASMA COAGULATION INDICATORS - THROMBIN ACTIVITY, PLASMA RECALCIFICATION TIME AND PLASMA TOLERANCE TO HEPARIN | 2020 |
|
RU2786591C2 |
HIGHLY-SELECTIVE INFESTIN 4-BASED INHIBITOR OF CONTACT ACTIVATION | 2013 |
|
RU2556116C2 |
WHOLE BLOOD THROMBINE ACTIVITY TEST | 2006 |
|
RU2422835C2 |
SOLUTION FOR CORRECTION OF PRIMARY HOMEOSTASIS DISORDER WITH PLASMA-SUBSTITUTING SOLUTIONS OF NOVEL COMPOSITION | 2005 |
|
RU2300385C1 |
NOVEL COMPOUNDS POSSESSING ANTICOAGULANT FUNCTION, BASED ON THEM PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF THROMBOTIC CONDITIONS AND PLASMA-SUBSTITUTING SOLUTION FOR CORRECTION OF HYPERCOAGULATION DISORDERS IN HEMODILUTION | 2007 |
|
RU2353619C2 |
REAGENT KIT FOR DIAGNOSING DEGREE OF NEUROINFLAMMATION | 2018 |
|
RU2698206C1 |
BLOOD AND ITS COMPONENTS SPATIAL COAGULATION STUDYING DEVICE | 2018 |
|
RU2682883C1 |
METHOD OF DETERMINING THROMBIN COMPLEMENTARITY SYSTEM ACTIVATION PATHWAY | 2019 |
|
RU2717946C1 |
DETERMINING HUMAN ERYTHROCYTE SENSITIVITY TO LYSIS WITH COMPLEMENT SYSTEM ACTIVATION ON THROMBIN PATHWAY | 2019 |
|
RU2696981C1 |
DETERMINING OF CIRCULATING THROMBIN IN COMPLEMENT ACTIVATION TEST | 2019 |
|
RU2709341C1 |
Authors
Dates
2014-06-10—Published
2011-07-26—Filed